Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Don’t Let the Gimmicky Apple Card Turn You Away From Visa Stock

By Josh Enomoto, InvestorPlace Contributor

The Apple Card’s debut has obvious implications for Visa stock, but the long-term impact towards the credit-card giant will be muted.

3 Reasons to Buy Microsoft Stock on Any Weakness

By Josh Enomoto, InvestorPlace Contributor

Microsoft stock may have gotten ahead of itself, but patient investors have several reasons to buy the eventual pullback.

5 Dow Jones Stocks for the End of Mueller’s Investigation

By Josh Enomoto, InvestorPlace Contributor

With the Mueller investigation finding no evidence of a Trump-Russia collusion, Dow Jones stocks have one less variable to worry about.

3 Things to Watch for Cronos Group Stock Ahead of Earnings

By Josh Enomoto, InvestorPlace Contributor

Although revenue growth is a strong point for Cronos Group stock, heightened expectations make Q4 a tricky situation for CRON stock holders.

3 Cheap Stocks to Buy That Are Worth Every Penny

By Josh Enomoto, InvestorPlace Contributor

With the major indices showing signs of hesitancy, now is an ideal time to consider lesser-known but viable cheap stocks.

Sprint Stock Isn’t Worth a Gamble for the T-Mobile Merger

By Josh Enomoto, InvestorPlace Contributor

Although we’ve heard compelling arguments for a T-Mobile-Sprint merger, future prospects for S stock remain shaky.

Should You Buy Bio-Path Stock After 5-Fold Gain? 3 Pros, 3 Cons

By Josh Enomoto, InvestorPlace Contributor

BPTH stock is easily one of 2019's top performers, but you’ve got to look at the whole Bio-Path story before jumping aboard.

Sony Stock Has Nothing to Fear From Alphabet’s Stadia

By Josh Enomoto, InvestorPlace Contributor

Alphabet’s new Stadia gaming platform seemingly threatens Sony stock, but a deeper look reveals nothing more than a paper tiger.

7 5G Stocks to Buy as the Race for Spectrum Tightens

By Josh Enomoto, InvestorPlace Contributor

Competition among 5G stocks is heating up as high-speed wireless companies jockey for position in a society-altering industry. Which stocks should you buy?

7 Video Game Stocks on Steep Discount

By Josh Enomoto, InvestorPlace Contributor

Video game stocks have gone awry in the wake of Google Stadia, making for plenty of discounted gaming stocks.

Load More